Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and toxicity profile of Pomalidomide
and Dexamethasone in relapsed or refractory Multiple Myeloma patients with deletion 17p or
translocation (4;14)